Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Kim

Showing results (411-420 of 446) with videos related to

Pageof 45
Sort By:
Plos One|October 27, 2010
A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North AmericaAlexander L Greninger, Eunice C Chen, Taylor Sittler, et al.
Plos One|February 18, 2010
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lungPing Yuan, Humam Kadara, Carmen Behrens, et al.
Vaccines|December 5, 2019
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine SchedulesZheng Quan Toh, Jennie Kosasih, Fiona M Russell, et al.
Pediatrics|June 25, 2021
Risk Factors and Outcomes After a Brief Resolved Unexplained Event: A Multicenter StudyJoel S Tieder, Erin Sullivan, Allayne Stephans, et al.
Oncotarget|October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaAnthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
The Lancet. Oncology|April 25, 2017
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 studyAllen M Chen, Carol Felix, Pin-Chieh Wang, et al.
Head & Neck|October 15, 2013
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cellsJ Hun Hah, Mei Zhao, Curtis R Pickering, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Pageof 45

Showing results (411-420 of 446) with videos related to

Sort By:
Pageof 45
Plos One|October 27, 2010
A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North AmericaAlexander L Greninger, Eunice C Chen, Taylor Sittler, et al.
Plos One|February 18, 2010
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lungPing Yuan, Humam Kadara, Carmen Behrens, et al.
Vaccines|December 5, 2019
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine SchedulesZheng Quan Toh, Jennie Kosasih, Fiona M Russell, et al.
Pediatrics|June 25, 2021
Risk Factors and Outcomes After a Brief Resolved Unexplained Event: A Multicenter StudyJoel S Tieder, Erin Sullivan, Allayne Stephans, et al.
Oncotarget|October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaAnthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
The Lancet. Oncology|April 25, 2017
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 studyAllen M Chen, Carol Felix, Pin-Chieh Wang, et al.
Head & Neck|October 15, 2013
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cellsJ Hun Hah, Mei Zhao, Curtis R Pickering, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Pageof 45